
Sign up to save your podcasts
Or


How does a vaccine get developed, studied, approved, distributed, and administered, and then just … disappear? On Episode 34 of The Politics of Everything, hosts Laura Marsh and Alex Pareene explore what happened to LYMErix, a vaccine for Lyme disease that has been called the only safe and effective vaccine ever to have been voluntarily withdrawn from the market in the United States. What does the story of LYMErix tell us about vaccine hesitancy, liability, and how pharmaceutical companies decide what to sell? And can we expect another Lyme vaccine anytime soon? Guests include Rebecca Onion, who wrote about LYMErix for Slate, and Andrew Zaleski, who wrote about new prophylactic treatments for Lyme for Outside magazine.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The New Republic & Talkhouse4.3
227227 ratings
How does a vaccine get developed, studied, approved, distributed, and administered, and then just … disappear? On Episode 34 of The Politics of Everything, hosts Laura Marsh and Alex Pareene explore what happened to LYMErix, a vaccine for Lyme disease that has been called the only safe and effective vaccine ever to have been voluntarily withdrawn from the market in the United States. What does the story of LYMErix tell us about vaccine hesitancy, liability, and how pharmaceutical companies decide what to sell? And can we expect another Lyme vaccine anytime soon? Guests include Rebecca Onion, who wrote about LYMErix for Slate, and Andrew Zaleski, who wrote about new prophylactic treatments for Lyme for Outside magazine.
Learn more about your ad choices. Visit megaphone.fm/adchoices

43,955 Listeners

141 Listeners

245 Listeners

388 Listeners

87,249 Listeners

308 Listeners

12,531 Listeners

5 Listeners

375 Listeners

1,519 Listeners

367 Listeners

158 Listeners

143 Listeners

42 Listeners

9,418 Listeners

771 Listeners

52 Listeners

14 Listeners

48 Listeners

64 Listeners

19 Listeners

31 Listeners

3 Listeners